AI + Digital Maturity in Contract Manufacturing
Exclusive Report

External Manufacturing Leaders Boston

CDMO Live Americas 2026 Early Bird

Agenda Download

Days

Hours

Minutes

Seconds

CDMO News

Emergent BioSolutions Signs $34.5 Million Agreement with Substipharm for JE Vaccine Manufacturing

Emergent BioSolutions Signs $50 Million Manufacturing Agreement with SAB Biotherapeutics

LTS Lohmann Expands CDMO Services to Ophthalmic Drug Delivery in U.S.

Mikart Opens New Atlanta Headquarters

PharmaLogic Opens PET Radiopharmaceutical Facility in Atlanta

Genezen Partners with Gray Foundation to Advance CLN6 Gene Therapy to Phase 1/2

DINAMIQS Secures Swissmedic License for Viral Vector cGMP Manufacturing

Kneat Signs Agreement with European CDMO to Digitize Validation Processes

OneSource Specialty Pharma Supports Health Canada Approval for Generic Ozempic®

Thermo Fisher Scientific Opens 4,000 Sq Ft Bioprocess Design Center in Massachusetts

BioDuro Partners with CTI Biotechnology to Build Integrated Preclinical Platform

More CDMO News

Emergent BioSolutions Signs $50 Million Manufacturing Agreement with SAB Biotherapeutics

LTS Lohmann Expands CDMO Services to Ophthalmic Drug Delivery in U.S.

Mikart Opens New Atlanta Headquarters

PharmaLogic Opens PET Radiopharmaceutical Facility in Atlanta

Genezen Partners with Gray Foundation to Advance CLN6 Gene Therapy to Phase 1/2

DINAMIQS Secures Swissmedic License for Viral Vector cGMP Manufacturing

Kneat Signs Agreement with European CDMO to Digitize Validation Processes

OneSource Specialty Pharma Supports Health Canada Approval for Generic Ozempic®

Thermo Fisher Scientific Opens 4,000 Sq Ft Bioprocess Design Center in Massachusetts

BioDuro Partners with CTI Biotechnology to Build Integrated Preclinical Platform

More CDMO News

White Paper[Download]

Why Compliance-Driven CDMOs Win Sponsor Contracts

RESOURCES

CDMO News

CDMO News

Emergent BioSolutions Signs $34.5 Million Agreement with Substipharm for JE Vaccine Manufacturing

Emergent BioSolutions Signs $34.5 Million Agreement with Substipharm for JE Vaccine Manufacturing

Emergent BioSolutions Signs $50 Million Manufacturing Agreement with SAB Biotherapeutics

LTS Lohmann Expands CDMO Services to Ophthalmic Drug Delivery in U.S.

Mikart Opens New Atlanta Headquarters

PharmaLogic Opens PET Radiopharmaceutical Facility in Atlanta

Genezen Partners with Gray Foundation to Advance CLN6 Gene Therapy to Phase 1/2

DINAMIQS Secures Swissmedic License for Viral Vector cGMP Manufacturing

Kneat Signs Agreement with European CDMO to Digitize Validation Processes

OneSource Specialty Pharma Supports Health Canada Approval for Generic Ozempic®

Thermo Fisher Scientific Opens 4,000 Sq Ft Bioprocess Design Center in Massachusetts

BioDuro Partners with CTI Biotechnology to Build Integrated Preclinical Platform

Emergent BioSolutions Signs $50 Million Manufacturing Agreement with SAB Biotherapeutics

LTS Lohmann Expands CDMO Services to Ophthalmic Drug Delivery in U.S.

Mikart Opens New Atlanta Headquarters

PharmaLogic Opens PET Radiopharmaceutical Facility in Atlanta

Genezen Partners with Gray Foundation to Advance CLN6 Gene Therapy to Phase 1/2

DINAMIQS Secures Swissmedic License for Viral Vector cGMP Manufacturing

Kneat Signs Agreement with European CDMO to Digitize Validation Processes

OneSource Specialty Pharma Supports Health Canada Approval for Generic Ozempic®

Thermo Fisher Scientific Opens 4,000 Sq Ft Bioprocess Design Center in Massachusetts

BioDuro Partners with CTI Biotechnology to Build Integrated Preclinical Platform

Why Compliance-Driven CDMOs Win Sponsor Contracts

CDMO Contract Negotiations Timelines Explained

Target Product Profile (TPP) Explained

Drug Development Readiness: Interactive Checklist and RACI

Welcome to PharmaSource

Follow us

Top Links

Get in touch